JP2017153484A5 - - Google Patents

Download PDF

Info

Publication number
JP2017153484A5
JP2017153484A5 JP2017096499A JP2017096499A JP2017153484A5 JP 2017153484 A5 JP2017153484 A5 JP 2017153484A5 JP 2017096499 A JP2017096499 A JP 2017096499A JP 2017096499 A JP2017096499 A JP 2017096499A JP 2017153484 A5 JP2017153484 A5 JP 2017153484A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequences
capsid proteins
consensus sequence
circulating strains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017096499A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017153484A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017153484A publication Critical patent/JP2017153484A/ja
Publication of JP2017153484A5 publication Critical patent/JP2017153484A5/ja
Pending legal-status Critical Current

Links

JP2017096499A 2008-08-08 2017-05-15 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子 Pending JP2017153484A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8750408P 2008-08-08 2008-08-08
US61/087,504 2008-08-08
US21860309P 2009-06-19 2009-06-19
US61/218,603 2009-06-19

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015075955A Division JP6448445B2 (ja) 2008-08-08 2015-04-02 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子

Publications (2)

Publication Number Publication Date
JP2017153484A JP2017153484A (ja) 2017-09-07
JP2017153484A5 true JP2017153484A5 (enExample) 2018-02-22

Family

ID=41664003

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011522301A Active JP5852883B2 (ja) 2008-08-08 2009-08-10 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子
JP2015075955A Active JP6448445B2 (ja) 2008-08-08 2015-04-02 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子
JP2017096499A Pending JP2017153484A (ja) 2008-08-08 2017-05-15 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2011522301A Active JP5852883B2 (ja) 2008-08-08 2009-08-10 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子
JP2015075955A Active JP6448445B2 (ja) 2008-08-08 2015-04-02 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子

Country Status (14)

Country Link
US (2) US8841120B2 (enExample)
EP (2) EP2324113B8 (enExample)
JP (3) JP5852883B2 (enExample)
KR (2) KR102118458B1 (enExample)
CN (2) CN102177233B (enExample)
AU (1) AU2009279456B2 (enExample)
CA (1) CA2733589C (enExample)
DK (1) DK2324113T3 (enExample)
ES (1) ES2668836T3 (enExample)
HK (1) HK1215051A1 (enExample)
NO (1) NO2324113T3 (enExample)
PL (1) PL2324113T3 (enExample)
SG (1) SG2013057732A (enExample)
WO (1) WO2010017542A1 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007345768B2 (en) * 2006-07-27 2013-08-01 Ligocyte Pharmaceuticals, Inc. Chimeric influenza virus-like particles
EP2601969B1 (en) 2006-09-29 2016-03-30 Takeda Vaccines, Inc. Norovirus vaccine formulations
CA2683977C (en) * 2007-03-14 2017-04-25 Ligocyte Pharmaceuticals, Inc. A method of norovirus virus-like particle purification comprising ion exchange chromatography
US10130696B2 (en) 2007-09-18 2018-11-20 Takeda Vaccines, Inc. Method of conferring a protective immune response to norovirus
US20100266636A1 (en) 2007-09-18 2010-10-21 Ligocyte Pharmaceuticals, Inc. Method of conferring a protective immune response to norovirus
NO2324113T3 (enExample) 2008-08-08 2018-07-28
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
JP2013533745A (ja) 2010-07-06 2013-08-29 ノバルティス アーゲー ノロウイルスに由来する免疫原性組成物および方法
CR20190540A (es) * 2011-07-11 2022-04-04 Takeda Vaccines Inc FORMULACIONES PARENTERALES DE VACUNAS CONTRA LOS NOVOVIRUS (Divisional 2014-0069)
JP2014527799A (ja) 2011-08-26 2014-10-23 ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション 変異型ｐｂ２遺伝子セグメントを有する弱毒化生ワクチンとしてのインフルエンザウイルス
JP6567824B2 (ja) * 2011-10-12 2019-08-28 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア ヒトパピローマウイルスのワクチンおよびその使用方法
JOP20130186B1 (ar) 2012-06-22 2021-08-17 Takeda Vaccines Montana Inc تنقية الجزيئات الشبيهة بالفيروسات
EP3586870A1 (en) 2013-03-12 2020-01-01 The Trustees Of The University Of Pennsylvania Improved vaccines for human papilloma virus and methods for using the same
JP6479305B2 (ja) 2013-07-12 2019-03-06 株式会社Ｕｍｎファーマ ウイルス様粒子の精製方法
JP2015015931A (ja) 2013-07-12 2015-01-29 株式会社Ｕｍｎファーマ ウイルス様粒子を含む培養物の製造方法
US10524493B2 (en) * 2013-09-16 2020-01-07 The Johns Hopkins University Compositions and methods for preventing or relieving symptoms of infections
SG10202107054TA (en) 2013-10-03 2021-08-30 Takeda Vaccines Inc Methods of detection and removal of rhabdoviruses from cell lines
AU2014354797C1 (en) * 2013-11-29 2018-02-01 Inovio Pharmaceuticals, Inc. MERS-CoV vaccine
WO2015196150A2 (en) 2014-06-20 2015-12-23 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
US10494613B2 (en) * 2015-08-28 2019-12-03 Wisconsin Alumni Research Foundation (Warf) Generation of infectious influenza viruses from virus-like particles
WO2017040265A1 (en) 2015-08-28 2017-03-09 Nanotherapeutics, Inc. Norovirus vaccine
KR102777995B1 (ko) * 2015-12-04 2025-03-10 시아먼 유니버시티 11형 인유두종 바이러스 엘1 단백질의 돌연변이체
US11197925B2 (en) 2016-02-19 2021-12-14 Wisconsin Alumni Research Foundation (Warf) Influenza B virus replication for vaccine development
CN110073005A (zh) 2016-06-03 2019-07-30 奎斯特诊断投资有限责任公司 检测诺如病毒的方法
CA3056812C (en) 2017-03-23 2022-11-29 Medicago Inc. Norovirus fusion proteins and vlps comprising norovirus fusion proteins
TWI743346B (zh) 2017-03-31 2021-10-21 國立大學法人東京大學 諾羅病毒抗體
JP6795468B2 (ja) * 2017-07-14 2020-12-02 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア ヒトパピローマウイルスのワクチンおよびその使用方法
WO2019079594A1 (en) * 2017-10-18 2019-04-25 The University Of North Carolina At Chapel Hill METHODS AND COMPOSITIONS FOR VACCINES AGAINST NOVOVIRUS AND DIAGNOSIS OF NOVOVIRUS
WO2019084310A1 (en) 2017-10-25 2019-05-02 Yoshihiro Kawaoka HAS RECOMBINANT INFLUENZA VIRUSES STABILIZED FOR EGG REPLICATION
CN109776657B (zh) * 2017-11-14 2021-11-26 北京康乐卫士生物技术股份有限公司 重组诺如病毒vlp颗粒和制备方法及其用途
KR102878449B1 (ko) 2017-11-30 2025-10-30 아라미스 바이오테크놀로지스 인코포레이티드 변형된 노로바이러스 vp1 단백질 및 변형된 노로바이러스 vp1 단백질을 포함하는 vlp
CA3083953A1 (en) * 2017-12-11 2019-06-20 Board Of Regents, The University Of Texas System Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration
CN110551183A (zh) * 2018-06-04 2019-12-10 厦门大学 一种人乳头瘤病毒39型l1蛋白的突变体
KR102075393B1 (ko) * 2018-06-28 2020-02-11 한국과학기술원 중증 열성 혈소판 감소 증후군(sfts) 바이러스 감염 질환 예방 또는 치료용 백신 조성물
WO2020010428A1 (en) 2018-07-13 2020-01-16 Medicago Inc. Modified norovirus vp1 proteins and vlps comprising modified norovirus vp1 proteins
US12343390B2 (en) 2018-08-07 2025-07-01 Wisconsin Alumni Research Foundation (Warf) Recombinant biologically contained filovirus vaccine
US11389523B2 (en) 2018-08-20 2022-07-19 Wisconsin Alumni Research Foundation (Warf) Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein
WO2020041192A1 (en) 2018-08-20 2020-02-27 Takeda Vaccines, Inc. Vlp formulations
AR117462A1 (es) * 2018-12-20 2021-08-04 Takeda Vaccines Inc Vacuna contra norovirus, formulaciones y métodos
JP7662157B2 (ja) 2019-02-08 2025-04-15 ウィスコンシン アルムニ リサーチ ファンデイション ヒト化細胞系
WO2020223699A1 (en) 2019-05-01 2020-11-05 Wisconsin Alumni Research Foundation (Warf) Improved influenza virus replication for vaccine development
JP7627911B2 (ja) 2019-08-27 2025-02-07 ウィスコンシン アルムニ リサーチ ファンデイション 卵内複製のための安定化されたｈａを持つ組換えインフルエンザウイルス
JP7075130B2 (ja) * 2019-10-25 2022-05-25 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア ヒトパピローマウイルスのワクチンおよびその使用方法
US11739303B2 (en) 2020-01-24 2023-08-29 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized NA
WO2021195410A1 (en) 2020-03-25 2021-09-30 Wisconsin Alumni Research Foundation (Warf) Recombinant multivalent influenza viruses
CN114316033A (zh) * 2020-09-29 2022-04-12 香港理工大学深圳研究院 一种特异性识别诺如病毒的单克隆抗体及制备方法与应用
US20240066112A1 (en) * 2020-12-30 2024-02-29 Grand Theravac Life Science (Nanjing) Co., Ltd. Norovirus virus-like particle, immune composition, or kit, and use thereof
JPWO2022244860A1 (enExample) * 2021-05-20 2022-11-24
US20240238401A1 (en) 2021-05-21 2024-07-18 Takeda Vaccines, Inc. Solid composition, freeze-drying method and glass vial
US20240402174A1 (en) 2021-10-04 2024-12-05 Takeda Vaccines, Inc. Methods for determining norovirus-reactive antibodies
EP4499138A1 (en) * 2022-03-25 2025-02-05 Merck Sharp & Dohme LLC Controlled release vaccine formulations

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572862B1 (en) 1989-11-08 2003-06-03 Baylor College Of Medicine Methods and reagents to detect and characterize Norwalk and related viruses
AU1893592A (en) 1991-03-25 1992-10-21 Board Of Trustees Of The Leland Stanford Junior University Norwalk virus human gastroenteritis agent and molecular cloning of corresponding cdnas
JPH07509122A (ja) * 1992-04-08 1995-10-12 ザ　ガバメント　オブ　ザ　ユナイテッド　ステイツ　オブ　アメリカ，アズ　レプリゼンテッド　バイ　ザ　セクレター，デパートメント　オブ　ヘルス　アンド　ヒューマン　サービシーズ 野生型麻疹ウイルス糖タンパク質：ワクチンおよびその検出方法
WO1994005700A2 (en) 1992-09-07 1994-03-17 Baylor College Of Medicine Methods and reagents to detect and characterize norwalk and related viruses
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
CN1152935A (zh) * 1994-05-16 1997-06-25 麦克公司 乳头状瘤病毒疫苗
US5645051A (en) 1995-04-21 1997-07-08 Dura Pharmaceuticals, Inc. Unit dose dry powder inhaler
US5861241A (en) 1995-08-16 1999-01-19 University Of Massachusetts Monoclonal antibodies for detecting Norwalk virus
GB9525083D0 (en) 1995-12-07 1996-02-07 Danbiosyst Uk Vaccine compositions
US5953727A (en) * 1996-10-10 1999-09-14 Incyte Pharmaceuticals, Inc. Project-based full-length biomolecular sequence database
US6491919B2 (en) 1997-04-01 2002-12-10 Corixa Corporation Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
EP0980257A1 (en) * 1997-05-01 2000-02-23 Chiron Corporation Use of virus-like particles as adjuvants
US20040265377A1 (en) 1997-10-27 2004-12-30 Harry Seager Solid dispersing vaccine composition for oral delivery
AU760633B2 (en) 1998-08-14 2003-05-22 Merck Sharp & Dohme Corp. Process for purifying human papillomavirus virus-like particles
CA2354444A1 (en) 1998-12-17 2000-06-22 Merck & Co., Inc. Synthetic virus-like particles with heterologous epitopes
KR100771402B1 (ko) 1999-06-22 2007-10-30 국립감염증연구소장이 대표하는 일본국 Ｓｒｓｖ 검출 킷트
JP2002020399A (ja) 2000-07-10 2002-01-23 Osaka Prefecture ノルウォークウイルス（ｎｖ）を認識するモノクローナル抗体
WO2003068993A1 (en) 2002-02-14 2003-08-21 Novavax, Inc. Method for isolation and purification of expressed gene products in vitro
BR0311995A (pt) * 2002-06-20 2005-04-05 Cytos Biotechnology Ag Partìculas semelhantes a vìrus empacotadas para o uso como adjuvantes: método de preparação e uso
WO2005032457A2 (en) 2003-07-21 2005-04-14 Boyce Thompson Institute For Plant Research, Inc. Vectors and methods for immunization against norwalk virus using transgenic plants
WO2005030806A2 (en) 2003-09-24 2005-04-07 Montana State University Norovirus monoclonal antibodies and peptides
WO2005037223A2 (en) 2003-10-15 2005-04-28 Brigham And Women's Hospital, Inc. Methods and compositions for immunomodulation
US20050215501A1 (en) 2003-10-24 2005-09-29 Coley Pharmaceutical Group, Inc. Methods and products for enhancing epitope spreading
FR2863890B1 (fr) 2003-12-19 2006-03-24 Aventis Pasteur Composition immunostimulante
US7481997B1 (en) * 2004-02-12 2009-01-27 Montana State University Snow mountain virus genome sequence, virus-like particles and methods of use
US20050260225A1 (en) 2004-05-18 2005-11-24 Goldberg Joanna B Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens
CU23496A1 (es) * 2004-09-03 2010-02-23 Ct Ingenieria Genetica Biotech Composición vacunal contra el virus de la hepatitis c
JP4993301B2 (ja) 2004-10-20 2012-08-08 サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー 日本脳炎ウイルスおよび西ナイルウイルスに対するワクチン
GB0428394D0 (en) 2004-12-24 2005-02-02 Chiron Srl Saccharide conjugate vaccines
US8168771B2 (en) * 2005-01-31 2012-05-01 The Johns Hopkins University Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
MX291624B (es) 2005-02-18 2011-11-04 Novartis Vaccines & Diagnostic Inmunogenos de escherichia coli uropatogenica.
CN101141979B (zh) 2005-03-18 2013-05-08 赛托斯生物技术公司 猫变应原融合蛋白及其用途
EP1736538A1 (en) 2005-06-21 2006-12-27 Cytos Biotechnology AG Process for the preparative purification of virus-like-particles (VLPs)
JP4825958B2 (ja) * 2005-08-10 2011-11-30 財団法人ヒューマンサイエンス振興財団 高リスク群ヒトパピローマウイルスの中和抗体を誘導する抗原
ES2514316T3 (es) * 2005-11-22 2014-10-28 Novartis Vaccines And Diagnostics, Inc. Partículas similares a virus (VLPs) de Norovirus y Sapovirus
JP2007145775A (ja) * 2005-11-29 2007-06-14 Falco Life Science:Kk ノロウイルスｇｉの高感度検出方法
EP2601969B1 (en) 2006-09-29 2016-03-30 Takeda Vaccines, Inc. Norovirus vaccine formulations
US20100266636A1 (en) 2007-09-18 2010-10-21 Ligocyte Pharmaceuticals, Inc. Method of conferring a protective immune response to norovirus
US10130696B2 (en) 2007-09-18 2018-11-20 Takeda Vaccines, Inc. Method of conferring a protective immune response to norovirus
NO2324113T3 (enExample) 2008-08-08 2018-07-28
CN102791286B (zh) * 2010-01-21 2017-08-08 莱戈赛特医药股份有限公司 杯状病毒病毒样颗粒上靶定异源抗原的呈递

Similar Documents

Publication Publication Date Title
JP2017153484A5 (enExample)
SG11201810014UA (en) Viral particle for rna transfer, especially into cells involved in immune response
WO2017015463A3 (en) Infectious disease vaccines
EP3199545A3 (en) Computationally optimized broadly reactive antigens for h1n1 influenza
WO2019126634A3 (en) Targeted integration of nucleic acids
JP2010227108A5 (enExample)
AU2014203512B2 (en) Recombinant virus-like particles encoded by multi-gene vector
JP2015524422A5 (enExample)
WO2016046778A3 (en) Protease-activatable bispecific proteins
HK1203524A1 (en) Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses
WO2018053365A8 (en) METHODS OF PREPARING NUCLEIC ACID SAMPLE FOR ANALYSIS OF ACELLULAR DNA
WO2017194902A3 (fr) Particule pour l'encapsidation d'un système d'ingénierie du génome
JP2013544069A5 (enExample)
JP2014512451A5 (enExample)
HK1203522A1 (en) Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses
WO2018011599A3 (en) Process for recovering viral products using functionalised chromatography media
ZA202100386B (en) Influenza virus hemagglutinin mutants
JP2010088434A5 (enExample)
BR112015006763B1 (pt) Constructo de ácido nucleico, vetor de transferência plasmídico, partículas de vírus mv-chik, composições, uso da composição, uso das partículas de vírus mv-chik e processo para resgatar vírus do sarampo (mv) recombinante
WO2012018907A3 (en) Polypeptides for treating and/or limiting influenza infection
RU2017122176A (ru) Новые способы дисплея циклических пептидов на частицах бактериофага
JP2013023516A5 (enExample)
JP2016511287A5 (enExample)
WO2013178627A3 (en) Protein assembler
WO2015112948A3 (en) Methods for determining a nucleotide sequence